You built the practice, the patient list, and the reputation. Now a buyer is offering you seven times EBITDA (earnings before interest, taxes, depreciation, and amortization — roughly, your practice's cash operating profit), a minority equity rollover, and a chance to "focus on medicine while we handle the business side." It sounds like a retirement plan wrapped in a compliment.
Here is the part the pitch deck leaves out: in a growing number of states, your sale is no longer a private transaction between you and the buyer. Regulators want advance notice, the paperwork to prove who really controls clinical decisions, and in some cases the power to block the deal. And before any of that, the buyer's accountants will tear through your books looking for reasons that seven-times multiple should really be five.
This guide walks through what veterinary and dental practice owners need to know before weighing a private-equity-backed sale in 2026: the new disclosure rules, how these deals are actually structured, and the bookkeeping cleanup that protects your price.
The Regulatory Backdrop Is No Longer Theoretical
For years, "corporate practice of medicine" bans sat quietly on state books while management-services arrangements worked around them. That era is ending. States are pairing old ownership doctrines with new transaction-review powers — and they have started enforcing both.
New York Wants Advance Notice on Vet Clinic Sales
In September 2025, New York's Assembly introduced a bill that would require acquiring entities to give notice and submit supporting documentation to the state Department of Agriculture and Markets before closing transactions involving a material change at a veterinary clinic — mergers, significant asset transfers, and deals that shift meaningful amounts of equity. Copies go to the antitrust, charities, and health care bureaus of the attorney general's office, and the attorney general would have the power to prohibit a transaction deemed contrary to the public interest.
If enacted, New York would be the first state to put veterinary deals through this kind of review. The threshold conversation centers on material changes rather than every small transaction, but any owner negotiating with a consolidator in New York should assume the timeline now includes a regulatory waiting period — and should build that into the purchase agreement's closing conditions instead of discovering it a week before the scheduled close.
California Is Enforcing, Not Just Legislating
California took the legislative route first: after a 2024 bill requiring attorney general consent for private-equity health care deals was vetoed, lawmakers returned with a 2025 measure restricting how private-equity-backed management services organizations and dental support organizations can influence medical and dental practices — including decisions about diagnosis, treatment, and referrals.
Then came the enforcement. In May 2026, California's attorney general announced a settlement with a private-equity-backed dental management company accused of crossing the line from administrative support into directing the practice, ownership, and management of dentistry, alongside false-advertising claims. The deal included $2 million in penalties, $300,000 in patient restitution, first-of-their-kind injunctive terms, and a multi-year compliance monitor.
The lesson for sellers is blunt: the management-services agreement the buyer hands you at closing is now a document regulators read. Structures where the buyer effectively controls scheduling, staffing levels, treatment protocols, or the hiring and firing of clinicians are exactly what examiners look for. If your deal leaves you as the "friendly" licensed owner on paper while the buyer calls every shot, understand that regulators in California — and states copying its playbook — treat that arrangement as the thing being regulated, not a way around the regulation.
Oregon and the Corporate-Practice Landmine
Oregon provided the other warning shot: a hospital operator walked away from plans to contract with an out-of-state staffing company after a federal judge characterized the arrangement as an attempt to circumvent the state's ban on the corporate practice of medicine. The structure never even got to operate — the legal characterization alone killed it.
For a selling owner, the takeaway is that these doctrines reach beyond hospitals into any licensed practice, including dental and veterinary. Before you sign, have independent health care counsel — not the buyer's counsel, not the broker who found the buyer — review who the documents say controls clinical decisions, and compare that to who actually will.
How These Deals Are Actually Structured
Understanding the standard structure is the only way to evaluate the price. Most private-equity practice acquisitions use some version of the same template.
The MSO/PC Split
The buyer typically cannot legally own your professional practice outright in a state with a corporate-practice ban. So the deal splits into two pieces: a management services organization (the buyer's entity) that buys the non-clinical assets and employs the non-licensed staff, and the professional corporation or PLLC — owned by a licensed professional, sometimes you, sometimes a buyer-affiliated clinician — that retains the clinical practice and pays the MSO a management fee.
That management fee is the economic engine of the whole deal, and it is also the document regulators scrutinize first. Fees set as a flat fair-market-value amount for actual services rendered are far easier to defend than fees that sweep all residual profit to the MSO. Ask how the fee was determined and whether an independent fair-market-value opinion supports it.
Cash, Rollover, Earnout, and the Work-Back
Headline multiples mislead because the consideration comes in slices:
- Cash at close — often 60 to 80 percent of the headline number.
- Equity rollover — you reinvest part of the proceeds into the buyer's holding company. This is where the "second bite of the apple" story lives: if the platform grows and sells again, your rollover appreciates. If it loads up on debt and stalls, it does not.
- Earnout — additional payments if the practice hits productivity or earnings targets after closing. Earnouts transfer performance risk to you after you have given up control — negotiate the metrics, the accounting rules used to measure them, and what happens if the buyer changes staffing, marketing, or fee schedules mid-stream.
- Work-back employment — the sale usually comes with a multi-year employment or contractor agreement for you. Price this honestly: a headline of seven times EBITDA paired with a five-year below-market work-back at high production is economically closer to a much lower multiple once you value your own labor. Run the math with your accountant before you fall in love with the multiple.
What This Means for Your Negotiating Position
Two things strengthen your hand more than anything: competitive tension (more than one bidder) and clean financials. You cannot always control the first. You can always control the second — and it is the subject of the next section.
The Numbers Buyers Will Scrutinize
A buyer's letter of intent is priced off a number called adjusted EBITDA. Your tax return shows one version of your earnings; the buyer constructs another by adding back one-time, non-recurring, and owner-specific costs to estimate what the practice earns under professional management. Every add-back they reject lowers your price. Every undocumented one never makes it into the conversation.
Build Your Add-Back Schedule Now
Start a simple schedule of adjustments for the last three years: your above-market salary (adjusted down to the cost of a replacement clinician), personal auto, family members on payroll who will not stay, one-time build-out or equipment costs, and related-party rent above market. The rule is documentation — an add-back without a receipt, lease, or payroll record behind it is a negotiation concession waiting to happen.
Clean Up Accounts Receivable and Payer Mix
Buyers discount what they cannot collect. Reconcile production reports to deposits, age your receivables, and write off the uncollectible balances you have been carrying. Know your collection ratio (collections divided by gross production, net of contractual adjustments) and your payer mix: heavy dependence on one or two PPO (preferred provider organization) insurance plans or a single corporate wellness contract reads as risk, and risk reads as a lower multiple. For veterinary practices, separate wellness-plan deferred revenue from earned revenue so the buyer sees recurring cash flow rather than a liability pile.
Separate the Personal From the Practice
Run personal expenses through the practice and you hand the buyer two weapons: they disallow the add-back for lack of substantiation, and they wonder what else in the books is unreliable. Move personal spending off the practice accounts at least a full year before a sale process. Keep owner distributions and salary clearly distinguished — buyers model future clinician compensation off your salary line, and a blended number confuses their model and your payout.
Count the Inventory
Dental supplies, implants, orthodontic materials, veterinary pharmacy stock, and controlled substances all sit on your balance sheet whether you track them or not. A buyer that finds six months of unordered supplies in a closet during diligence will assume the worst about everything else. Do a physical count, write down expired and obsolete stock, and reconcile the result to the books. For controlled substances, make sure acquisition and dispensing logs reconcile — diligence teams check, and so do regulators.
Disclosure Obligations Now Sit on the Seller Too
The new transaction-review regimes generally put filing duties on the acquiring entity, but sellers feel the consequences: delayed closings, busted timelines, and purchase agreements that let the buyer walk if approval does not arrive.
Three practical steps:
- Map every state that touches the deal. Where the practice sits, where the buyer is domiciled, and where patients or clients pay from can each trigger different notice rules. Multi-location sellers need a filing calendar, not a guess.
- Negotiate the regulatory clock in the purchase agreement. Define who prepares filings, set outside dates that accommodate review periods, and allocate the risk of a prohibition or imposed conditions — including whether the buyer must accept conditions to get the deal through.
- Expect reps and warranties about compliance. Buyers now ask sellers to warrant that existing management arrangements, fee structures, and referral relationships comply with corporate-practice and fee-splitting rules. Do not sign those representations until your own counsel has tested them against the current enforcement posture, not the posture from when the arrangements were drafted.
A Pre-Sale Bookkeeping Checklist
If a sale is even two years away, work through this list. Each item either raises your multiple or shortens diligence — both are money.
- Close the books monthly and reconcile every bank, credit card, and merchant account — unreconciled accounts are the first thing diligence flags.
- Track revenue by stream: clinical production, product and pharmacy resale, boarding or grooming, membership and wellness plans, lab and imaging. Buyers pay for visibility.
- Record deferred revenue for prepaid plans and deposits instead of booking cash as income on receipt.
- Keep a fixed-asset register with dates, costs, and depreciation — buyers verify equipment values and remaining useful life.
- Document related-party transactions (your building lease to yourself is the classic) with signed agreements at defensible rates.
- File and pay payroll and sales/use tax on time, every time — open tax liabilities give buyers a price chip and can delay closing.
- Separate each location's profit and loss if you run more than one site — platform buyers value the pattern across sites, not just the total.
Simplify Your Financial Management
Whether you sell next year or run the practice for another decade, buyers, lenders, and regulators all reward the same thing: books that reconcile, revenue you can explain by stream, and records that survive scrutiny. Beancount.io offers plain-text accounting that is transparent, version-controlled, and AI-ready — so your financial history is always complete, auditable, and yours. Get started for free and build the kind of clean books that hold up in diligence.